These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15699095)

  • 1. A snapshot of workplace drug testing in the UK.
    George S
    Occup Med (Lond); 2005 Jan; 55(1):69-71. PubMed ID: 15699095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns in drug use in the United Kingdom as revealed through analysis of hair in a large population sample.
    Tsanaclis L; Wicks JF
    Forensic Sci Int; 2007 Aug; 170(2-3):121-8. PubMed ID: 17614228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse in the workplace: epidemiology, effects, and industry response.
    Bush DM; Autry JH
    Occup Med; 2002; 17(1):13-25, iii. PubMed ID: 11726333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug use and drug trends in Sweden 2010-2020 - results from urine drug testing in the workplace].
    Helander A; Villen T
    Lakartidningen; 2021 Sep; 118():. PubMed ID: 34515329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A snapshot of workplace drug testing in Italy.
    Santoro PE; De Nardis I; Fronterrè P; Felli M; Martello S; Bergamaschi A; Chiarotti M
    Drug Test Anal; 2012 Feb; 4(2):66-70. PubMed ID: 22362571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new challenge for drug-free workplace programs.
    DuPont RL; Martin DM; Skipper GE
    Occup Health Saf; 2012 Feb; 81(2):32, 34. PubMed ID: 22435238
    [No Abstract]   [Full Text] [Related]  

  • 9. LC-MS: a powerful tool in workplace drug testing.
    Gallardo E; Barroso M; Queiroz JA
    Drug Test Anal; 2009 Mar; 1(3):109-15. PubMed ID: 20355182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protocol to evaluate drug-related workplace impairment.
    Reisfield GM; Shults T; Demery J; Dupont R
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):43-8. PubMed ID: 23527668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New technology and new initiatives in U.S. workplace testing.
    Walsh JM
    Forensic Sci Int; 2008 Jan; 174(2-3):120-4. PubMed ID: 17434275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluid testing: new technology enables drug testing without embarrassment.
    Cone EJ
    J Calif Dent Assoc; 2006 Apr; 34(4):311-5. PubMed ID: 16900989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview on drug and alcohol testing in the workplace.
    Hanson M
    Bull Narc; 1993; 45(2):3-44. PubMed ID: 7920541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of drug abuse among workers: strengths and pitfalls of the recent Italian Workplace Drug Testing (WDT) legislation.
    Kazanga I; Tameni S; Piccinotti A; Floris I; Zanchetti G; Polettini A
    Forensic Sci Int; 2012 Feb; 215(1-3):46-50. PubMed ID: 21482052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Professional drivers and psychoactive substances consumption: results from medical surveillance at the workplace in Piedmont region].
    Rosso GL; Feola M; Rubinetto MP; Petti N; Rubinetto L
    G Ital Med Lav Ergon; 2011; 33(3 Suppl):203-6. PubMed ID: 23393836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs and alcohol in the workplace.
    Jones R
    Occup Health (Lond); 1996 Nov; 48(11):396-9. PubMed ID: 9283471
    [No Abstract]   [Full Text] [Related]  

  • 19. Current practice and experience in drug and alcohol testing in the workplace.
    Zwerling C
    Bull Narc; 1993; 45(2):155-96. PubMed ID: 7920540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug testing in the workplace.
    Phan HM; Yoshizuka K; Murry DJ; Perry PJ
    Pharmacotherapy; 2012 Jul; 32(7):649-56. PubMed ID: 22605533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.